Skip to main content

Closed

OPRX: OptimizeRx Corp. Stock Analysis | finqOS

Healthcare · Medical - Healthcare Information Services

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Operating margin13.6%

ROIC6.5%

Financially safe

Adequate

Debt / equity0.18×

Interest coverage2.8×

Current ratio5.37×

Valuation

Unrated

P/E ratio16.5×

OptimizeRx Corp.

OPRXNASDAQ·USD·Closed

OptimizeRx Corp.

OPRXNASDAQ·USD·Closed

$6.05

−3.51%

$6.05

−$0.22 (3.51%)

52W Range

9thpctl

Volume

0.65×avg

Mkt Cap

113.53MUSD

P/E

16.5TTM

Div Yield

–ann

52W Range

9thpctl

Volume

0.65×avg

Market Cap

113.53MUSD

P/E Ratio

16.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings